Boc-L-Chg-OH*DCHA

Boc-L-Chg-OH*DCHA is a Boc-protected L-chiral amino acid derivative supplied as a dicyclohexylamine (DCHA) salt, combining a carbocyclic side chain with a tert-butoxycarbonyl (Boc) group on the amino functionality. This protected, salt-formed reagent is designed for controlled handling and reliable incorporation into peptide synthesis workflows, where the Boc group serves as the N-terminal protection strategy and the side-chain stereochemistry contributes to the conformational and steric profile of the resulting peptide segment. In synthetic and medicinal chemistry settings, it is typically selected when a chiral "Chg" residue is needed as a building block for defined structure in peptide-like scaffolds.

1. Solid-Phase Peptide Synthesis

Boc-L-Chg-OH*DCHA is used as a protected amino acid building block for assembling peptide sequences on solid supports, where the Boc protection strategy supports stepwise chain construction and purification workflows. Peptide synthesis groups preparing constrained or stereochemically defined analogs often choose this residue to introduce the characteristic "Chg" side-chain geometry, enabling consistent downstream coupling and fragment assembly during custom peptide synthesis. The DCHA salt form is commonly favored in peptide reagent handling because it can improve practical weighing, reduce hygroscopicity relative to some free-acid forms, and support reproducible reagent performance across multi-step syntheses.

2. Medicinal Chemistry Peptidomimetics

Boc-L-Chg-OH*DCHA is frequently incorporated into medicinal chemistry programs that generate peptide-like scaffolds and peptidomimetic analogs requiring a specific chiral amino acid motif. Researchers developing structure-activity relationship (SAR) libraries use this protected building block to vary stereochemical and steric elements at defined positions, supporting systematic evaluation of how residue-level changes affect the properties of the resulting analogs. The Boc-protected format aligns with common synthetic routes used to prepare protected intermediates and peptide fragments prior to final deprotection and coupling into larger lead structures.

3. Pharmaceutical Intermediate Manufacturing

Boc-L-Chg-OH*DCHA serves as a practical intermediate input for manufacturing workflows that require a stable, protected chiral amino acid unit for downstream segment coupling and final scaffold assembly. Process chemists and custom synthesis teams use this reagent when a defined, stereochemically consistent "Chg" residue must be introduced into larger peptide or peptide-derived intermediates, supporting reliable batch-to-batch reproducibility in multi-step production. The Boc protection and salt formulation are particularly relevant in industrial intermediate development, where controlled reactivity and manageable handling characteristics are essential for scaling protected amino acid chemistry into larger synthesis campaigns.

4. Stereodefined Chiral Fragment Building

Boc-L-Chg-OH*DCHA is applied when stereodefined chiral fragments are required to control the 3D presentation of side-chain substituents in peptide segments and peptide-derived materials. Chemical biology and structural chemistry teams preparing defined analogs for binding studies, conformational investigations, or protein-interaction mapping often select this building block to ensure the "Chg" residue contributes a consistent chiral environment at the intended position. The combination of Boc protection and preserved L-configuration makes it a convenient reagent for constructing chiral sequences where residue identity and stereochemical fidelity are critical to interpret downstream experimental outcomes.

1. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

3. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

4. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum